Monoclonal Antibody Therapeutics Market Is Estimated To Witness High Growth Owing To Increasing Incidence of Chronic Diseases
Monoclonal Antibody Therapeutics Market The global Monoclonal Antibody Therapeutics Market is estimated to be valued at US$ 205,385.6 million in 2022 and is expected to exhibit a CAGR of 12.69% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. A) Market Overview: The Monoclonal Antibody Therapeutics Market involves the use of monoclonal antibodies (mAbs) as targeted therapies for various diseases, including cancer, autoimmune disorders, infectious diseases, and cardiovascular diseases. These mAbs are designed to bind to specific proteins or cells in the body and modulate the immune response. They can be used alone or in combination with other therapies to improve treatment outcomes. The market offers a range of mAb products, such as therapeutic antibodies, diagnostic reagents, and research tools, which find applications in both clinical and research settings. B) Market Dynamics: The market for Monoclonal Antibody Therapeu...